scholarly article | Q13442814 |
P2093 | author name string | Herbert P Schweizer | |
Richard A Moore | |||
Donald T Moir | |||
Donald E Woods | |||
Ming Di | |||
P2860 | cites work | A comparison of antibiotic susceptibility testing methods for cotrimoxazole with Burkholderia pseudomallei. | Q39356268 |
Isolation of polymyxin B-susceptible mutants of Burkholderia pseudomallei and molecular characterization of genetic loci involved in polymyxin B resistance. | Q39472156 | ||
Transcriptome analysis of the response of Pseudomonas aeruginosa to hydrogen peroxide | Q40377337 | ||
Peptide inhibitors of the essential cell division protein FtsA. | Q40435544 | ||
Analysis and construction of stable phenotypes in gram-negative bacteria with Tn5- and Tn10-derived minitransposons | Q40687515 | ||
Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa | Q41781241 | ||
Evaluation of NAD(+) -dependent DNA ligase of mycobacteria as a potential target for antibiotics | Q41895644 | ||
A high-throughput, homogeneous, bioluminescent assay for Pseudomonas aeruginosa gyrase inhibitors and other DNA-damaging agents | Q43114724 | ||
Gene expression in Pseudomonas aeruginosa biofilms | Q43777487 | ||
Role of efflux pumps and mutations in genes for topoisomerases II and IV in fluoroquinolone-resistant Pseudomonas aeruginosa strains | Q44786412 | ||
Chemical evolution of the fluoroquinolone antimicrobial agents | Q45743334 | ||
Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa | Q46397999 | ||
Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase | Q47986775 | ||
Antimicrobial resistance in Burkholderia pseudomallei. | Q54062578 | ||
Analysis of Pseudomonas gene products using lacIq/Ptrp-lac plasmids and transposons that confer conditional phenotypes | Q57936335 | ||
The N-terminus promotes oligomerization of the Escherichia coli initiator protein DnaA | Q73129161 | ||
Integration-proficient plasmids for Pseudomonas aeruginosa: site-specific integration and use for engineering of reporter and expression strains | Q73301855 | ||
Transcriptome analysis of the Pseudomonas aeruginosa response to iron | Q79088334 | ||
Experimental Determination and System Level Analysis of Essential Genes in Escherichia coli MG1655 | Q22065459 | ||
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen | Q22122393 | ||
From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathways | Q24539226 | ||
Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei | Q24550664 | ||
Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei | Q24564168 | ||
An improved method for rapid generation of unmarked Pseudomonas aeruginosa deletion mutants | Q24815663 | ||
A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays | Q28145712 | ||
Halving of mortality of severe melioidosis by ceftazidime | Q28257666 | ||
Coordinate regulation of bacterial virulence genes by a novel adenylate cyclase-dependent signaling pathway | Q28492538 | ||
Regulation of pyocin genes in Pseudomonas aeruginosa by positive (prtN) and negative (prtR) regulatory genes | Q28492731 | ||
GeneChip expression analysis of the iron starvation response in Pseudomonas aeruginosa: identification of novel pyoverdine biosynthesis genes | Q28492754 | ||
Defining the Pseudomonas aeruginosa SOS response and its role in the global response to the antibiotic ciprofloxacin | Q29346807 | ||
Drugs for bad bugs: confronting the challenges of antibacterial discovery | Q29547723 | ||
Comprehensive transposon mutant library of Pseudomonas aeruginosa | Q29614861 | ||
Acetylornithinase of Escherichia coli: partial purification and some properties | Q29615297 | ||
Database resources of the National Center for Biotechnology Information: 2002 update | Q30782351 | ||
Panel of Bacillus subtilis reporter strains indicative of various modes of action | Q31081404 | ||
Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis | Q31876656 | ||
BpeAB-OprB, a multidrug efflux pump in Burkholderia pseudomallei | Q33200347 | ||
Discovering the mechanism of action of novel antibacterial agents through transcriptional profiling of conditional mutants | Q33803840 | ||
Pathogenesis of and immunity to melioidosis | Q33837734 | ||
Microarray analysis and functional characterization of the nitrosative stress response in nonmucoid and mucoid Pseudomonas aeruginosa. | Q34350755 | ||
Contribution of gene loss to the pathogenic evolution of Burkholderia pseudomallei and Burkholderia mallei | Q34758894 | ||
Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production. | Q37119379 | ||
Transcriptome analysis of quorum-sensing regulation and virulence factor expression in Pseudomonas aeruginosa | Q38333629 | ||
The epidemiology of melioidosis in Australia and Papua New Guinea | Q38958168 | ||
P921 | main subject | Pseudomonas aeruginosa | Q31856 |
Burkholderia pseudomallei | Q140475 | ||
P304 | page(s) | S152-62 | |
P577 | publication date | 2008-12-01 | |
P1433 | published in | Transactions of the Royal Society of Tropical Medicine and Hygiene | Q15766916 |
P1476 | title | Cellular reporter screens for inhibitors of Burkholderia pseudomallei targets in Pseudomonas aeruginosa | |
P478 | volume | 102 Suppl 1 |
Q35816288 | Depletion of M. tuberculosis GlmU from Infected Murine Lungs Effects the Clearance of the Pathogen |
Q33908076 | Development and application of a cellular, gain-of-signal, bioluminescent reporter screen for inhibitors of type II secretion in Pseudomonas aeruginosa and Burkholderia pseudomallei |
Q33533545 | Discovery and characterization of inhibitors of Pseudomonas aeruginosa type III secretion |
Q35960740 | Discovery of bacterial fatty acid synthase type II inhibitors using a novel cellular bioluminescent reporter assay |
Q33622815 | Mutations in the Pseudomonas aeruginosa needle protein gene pscF confer resistance to phenoxyacetamide inhibitors of the type III secretion system |
Q28493113 | The Pseudomonas aeruginosa periplasmic protease CtpA can affect systems that impact its ability to mount both acute and chronic infections |
Search more.